Found: 12
Select item for more details and to access through your institution.
The Effectiveness of No or Low-Dose versus High-Dose Aspirin in Treating Acute Kawasaki Disease: A Systematic Review and Meta-Analysis.
- Published in:
- Clinics & Practice, 2024, v. 14, n. 4, p. 1296, doi. 10.3390/clinpract14040105
- By:
- Publication type:
- Article
Immunogenicity of Hepatitis B Vaccination in Patients with Ulcerative Colitis on Infliximab Is Attenuated Compared to Those on 5-Aminosalicylic Acid Therapies: A Prospective Observational Study.
- Published in:
- Vaccines, 2024, v. 12, n. 4, p. 364, doi. 10.3390/vaccines12040364
- By:
- Publication type:
- Article
Effectiveness of vedolizumab and ustekinumab as second biologic agent in achieving target outcomes in tumor necrosis factor antagonists experienced patients with inflammatory bowel disease (enroll-ex study).
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1243080
- By:
- Publication type:
- Article
Biologic Therapies for the Treatment of Post-ileal Pouch Anal Anastomosis Surgery Chronic Inflammatory Disorders: Systematic Review and Meta-analysis.
- Published in:
- Journal of the Canadian Association of Gastroenterology, 2022, v. 5, n. 6, p. 287, doi. 10.1093/jcag/gwac026
- By:
- Publication type:
- Article
The Role of Clinical Pharmacists in Improving Quality of Care in Patients with Inflammatory Bowel Disease: An Evaluation of Patients' and Physicians' Satisfaction.
- Published in:
- Healthcare (2227-9032), 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/healthcare10101818
- By:
- Publication type:
- Article
COVID-19 Vaccine Booster Dose Willingness among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study.
- Published in:
- Vaccines, 2022, v. 10, n. 8, p. 1166, doi. 10.3390/vaccines10081166
- By:
- Publication type:
- Article
Impact of biologics and small molecules for inflammatory bowel disease on COVID‐19‐related hospitalization and mortality: A systematic review and meta‐analysis.
- Published in:
- JGH Open, 2022, v. 6, n. 4, p. 241, doi. 10.1002/jgh3.12728
- By:
- Publication type:
- Article
Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies.
- Published in:
- Vaccines, 2021, v. 9, n. 12, p. 1471, doi. 10.3390/vaccines9121471
- By:
- Publication type:
- Article
Immunogenicity of BNT162b2 Vaccine in Patients with Inflammatory Bowel Disease on Infliximab Combination Therapy: A Multicenter Prospective Study.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 22, p. 5362, doi. 10.3390/jcm10225362
- By:
- Publication type:
- Article
1141-P: Short-Chain Fatty Acid Acetate Increases TNF-a-Induced MCP-1 Production in Monocytes via the ACSL-1/MAPK/NF-?B Axis: Significance for Inflammation and Insulin Resistance.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-1141-P
- By:
- Publication type:
- Article
1139-P: CD36/FABP4/PPAR-d Axis-Induced Inflammation Is Dependent on ACSL1 under the Influence of Acute High-Fat Feeding.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-1139-P
- By:
- Publication type:
- Article
200-LB: Ceramide Kinase CERK Regulates Inflammatory Responses in Monocytes/Macrophages Induced by TNF-a.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-200-LB
- By:
- Publication type:
- Article